LA EXTENDED CARE OF NATCHITOCHES
1. Target Overview & Investment Thesis
LA EXTENDED CARE OF NATCHITOCHES is a 9-bed rural/critical access in NATCHITOCHES PARISH, LA with $6.1M in net patient revenue and a 0.4% operating margin. The hospital serves a payer mix of 65.0% Medicare, 13.8% Medicaid, and 21.2% commercial.
Thesis: Turnaround. Our ML models identify $460K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.4% to 7.9% (+753bps).
| Net Revenue HCRIS | $6.1M |
| Current EBITDA COMPUTED | $24K |
| Operating Margin COMPUTED | 0.4% |
| Occupancy HCRIS | 68.7% |
| Revenue / Bed COMPUTED | $679K |
| Net-to-Gross HCRIS | 43.8% |
| Distress Probability ML | 49.8% |
2. Market Context & Competitive Position
LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of 0.4% places it above the state median. Among 25 size-comparable peers (4-18 beds), the median margin is 11.8%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (4-18), prioritizing same-state peers. 25 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| LA EXTENDED CARE OF NATCHITOCH (Target) | LA | 9 | $6.1M | 0.4% |
| SPECIALISTS HOSPITAL OF SHREVE | LA | 15 | $79.1M | 21.3% |
| PARK PLACE SURGERY CENTER | LA | 10 | $51.6M | 15.4% |
| SURGICAL SPECIALTY CENTER BATO | LA | 16 | $49.8M | 16.9% |
| REEVES MEMORIAL MEDICAL CENTER | LA | 15 | $34.0M | 64.5% |
| MONROE SURGICAL HOSPITAL | LA | 10 | $25.8M | -11.9% |
| DOCTORS HOSPITAL OF SLIDELL LL | LA | 10 | $20.7M | 21.0% |
| ACADIA-ST. LANDRY HOSPITAL | LA | 15 | $15.5M | -6.3% |
| RIVERSIDE HOSPITAL OF LOUISIAN | LA | 14 | $13.7M | 2.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $460K (753bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $128K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $126K | +206bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $122K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $74K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +16bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $24K |
| + RCM Uplift | +$460K |
| Pro Forma EBITDA | $484K |
| Current Margin | 0.4% |
| Pro Forma Margin | 7.9% |
| WC Released (1x) | $234K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $37K | $4.8M | 129.85x | 164.7% |
| Base (11x exit) | 10.0x | 11.0x | $37K | $5.2M | 143.16x | 169.9% |
| Bull Case | 9.0x | 11.0x | $33K | $6.8M | 205.46x | 190.1% |
| Bull (12x exit) | 9.0x | 12.0x | $33K | $7.4M | 224.44x | 195.3% |
| Bear Case | 11.0x | 10.0x | $40K | $2.4M | 60.68x | 127.3% |
| Bear (11x exit) | 11.0x | 11.0x | $40K | $2.7M | 67.07x | 131.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Heavy Medicare dependence | Medicare comprises 65.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 25 hospitals with 4-18 beds
- Same-state prioritization (n=26)
- Comp margins: P25=-5.7% / P50=11.8% / P75=21.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.